Genetically-Engineered Vaccine for Melanoma Patients

Schuchter, Lynn M.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 5R01CA067776-02
• Application #: 2111547
• Study Section: Special Emphasis Panel (SRC (14))
• Project Start: 1995-08-25
• Project End: 1998-07-31
• Budget Start: 1996-08-01
• Budget End: 1997-07-31
• Support Year: 2
• Fiscal Year: 1996

Institution

• Name: University of Pennsylvania
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 042250712
• City: Philadelphia
• State: PA
• Country: United States
• Zip Code: 19104

Publications

Smith, J G; Eck, S L (1999) Molecular characterization of an adenoviral vector resulting from both homologous and nonhomologous recombination. Cancer Gene Ther 6:475-81

Boxhorn, H K; Smith, J G; Chang, Y J et al. (1998) Adenoviral transduction of melanoma cells with B7-1: antitumor immunity and immunosuppressive factors. Cancer Immunol Immunother 46:283-92